Laurel Springs, NC, United States of America

Erik Emstad

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Elevation Spine, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erik Emstad. Retrieved from https://idiyas.com/inventor/erik-emstad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Erik Emstad and His Work in Spinal Implant Innovation.

Introduction

Erik Emstad is an inventor associated with Laurel Springs, North Carolina, and Elevation Spine, Inc. His patent work includes an expandable intervertebral implant, a device designed for use in spinal procedures. Emstad is credited with 1 patent.

Latest Patents

Emstad’s listed patent is titled “Expandable Intervertebral Implant.” The invention concerns an implant that can expand within the intervertebral space, reflecting an engineering approach to spinal implant design.

Career Highlights

Emstad’s patent record highlights his contribution to medical-device innovation through work associated with Elevation Spine, Inc. The available information identifies his role as an inventor but does not provide further details about his career history.

Collaborations

Emstad’s listed coworkers include Andrea Cragen and Charles Gilbride. Their names provide context for the professional network associated with his work at Elevation Spine, Inc.

Conclusion

Erik Emstad’s recorded invention, the “Expandable Intervertebral Implant,” represents his documented contribution to spinal implant innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…